Andras Simon

Title: Andras Simon: Innovator in Retinol Dehydrogenase Research

Introduction

Andras Simon is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of biochemistry, particularly in the study of retinol dehydrogenases. With a total of 4 patents to his name, Simon's work has implications for understanding various biological processes.

Latest Patents

Among his latest patents, Simon has developed isolated proteins that exhibit retinol dehydrogenase activity. These proteins associate with retinol binding receptors and include isolated membrane-associated proteins with a molecular weight ranging from about 30 kD to about 36 kilodaltons, as determined by SDS-PAGE. His research also discloses proteins with cis retinol dehydrogenase activity, such as 9, 11, or 13 cis retinol dehydrogenase activity, and other trans-retinol dehydrogenases. Additionally, he has isolated nucleic acid molecules that code for these proteins, including a 32 kDA protein with 11-cis retinol dehydrogenase activity that associates with P63, a component of the retinol binding protein receptor.

Career Highlights

Andras Simon is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research. His work has garnered attention for its potential applications in cancer research and treatment.

Collaborations

Simon has collaborated with notable colleagues, including Ulf Eriksson and Anna Romert, contributing to a dynamic research environment that fosters innovation.

Conclusion

Andras Simon's contributions to the field of retinol dehydrogenase research highlight his role as an influential inventor. His patents and ongoing research continue to pave the way for advancements in biochemistry and cancer research.